Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Combi 3 Tablet
- Development stage
- Unknown
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes, Small Molecules
- Administration
- Oral
01
Overview
Combi 3 Tablet is a combination pharmaceutical product containing three active ingredients: diclofenac, paracetamol (acetaminophen), and serratiopeptidase. It is primarily used for relieving symptoms such as fever, pain, and inflammation associated with musculoskeletal and joint disorders, as well as for post-operative pain, redness, and swelling. Diclofenac, a non-steroidal anti-inflammatory drug (NSAID), and paracetamol, an analgesic and antipyretic, work by interfering with the production of prostaglandins, chemical substances responsible for swelling and pain. Serratiopeptidase, a proteolytic enzyme, aids in breaking down or dissolving abnormal proteins at the site of inflammation, thereby promoting healing.
- Brand names
- Combi 3 TabletCombi3 TabletCombi-3 Tablet
02
Targets
COX-3 (Mitochondrially encoded cytochrome c oxidase subunit 3)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)
Beyond the preview
Go deeper on Combi 3 Tablet.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Combi 3 Tablet.